NeurologyLive ®

Clinical Focus

Video Series

Publications

April 2019
Current Issue
Biofluid Biomarkers Hold Promise for the Future of Huntington Disease
Creativity, Persistence Are Key to Advancing the Approach to MS Symptom Management
Tele-Epilepsy: The Next Step in Telemedicine
Risdiplam Preliminary Phase 2 Data Show Improvement in Adults With Spinal Muscular Atrophy
Disease Management on the Horizon in Alzheimer Disease
Sigma-1 Agonists Offer Combination Approach to Dementia Symptoms
Efforts to Cure SMA Follow Multiple Pathways

Follow us:
  

Intellisphere, LLC
2 Clarke Drive, Suite 100
Cranbury, NJ 08512
P: (609) 716-7777

Copyright © 2018 NeurologyLive. Intellisphere, LLC. All Rights Reserved.
NeurologyLive does not provide medical, diagnostic, or treatment advice.

Insight from Osama Zaidat, MD
Neuroform Atlas Stent System Receives FDA Approval for Brain Aneurysms
This is the second aneurysm adjunctive stent to be granted premarket approval for treatment of wide-neck, intracranial aneurysms in conjunction with embolic detachable coils. 
Gastrointestinal Manifestations in hATTR Amyloidosis
Insight regarding the relationship between amyloid deposition and its impact on the gastrointestinal tract.
Automated Epilepsy Diagnostic Monitoring Systems Are Effective, Study Finds
The automated system detected epileptic seizures and psychogenic non‐epileptic seizures with a sensitivity of 72.7% and specificity of 100%. The positive and negative predictive values for PNES classification were 81.3% and 100%, respectively.
American Stroke Association Updates Stroke Systems of Care to Improve Patient Outcomes
The recommendations translate important scientific knowledge and innovations in clinical care into improvements in patient outcomes.
FDA Approves Midazolam Nasal Spray for Seizure Clusters
Nayzilam is now the first and only FDA-approved nasal option for treating seizure clusters.
Genetic Testing in hATTR Amyloidosis
Rebecca Ichord, MD: Addressing Pediatric Stroke With Thrombectomy and Thrombolysis
New Guideline for Tourette Syndrome, Tic Disorders, FDA Approves sBLA for IncobotulinumtoxinA for Blepharospasm, Gaboxadol Shows Clinical Benefit in Angelman Syndrome

SAP Partner Banner
Forgot password?